Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

But there’s another virus out there that can also cause these symptoms: It’s called respiratory syncytial virus (RSV), and ...

A new study published in the journal of Open Forum Infectious Diseases showed that older adults hospitalized with respiratory ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

Antibodies from the Abrysvo vaccine will be passed from the mothers to the babies. Read more at straitstimes.com.

With an expected rise in cases of common colds - seasonal influenaa, respiratory syncytial virus, and other respiratory infections, the Simcoe Muskoka District Health Unit (SMDHU) is recommending that ...

Rising cases of severe respiratory syncytial virus (RSV) in kids show new warning signs, highlighting the need for increased ...

Merck's (MRK) monoclonal antibody clesrovimab shows cuts RSV infections by 60% in infants, with a strong safety profile. Read ...